“Well organized office. Great staff. First visit involved emergency repair of torn retina by Dr. Schwartz for which I was very appreciative. He and the staff continue with follow up care. Many thanks.”
Branch vs. Central Retinal Artery Occlusion: Is a Branch Occlusion Still an Emergency?
What These Two Blockages Are
Both types of retinal artery occlusion involve a sudden loss of blood flow to part of the retina, the light-sensitive tissue lining the back of the eye. The key difference is which vessel is blocked and how much of the retina is affected as a result.
The central retinal artery is the main supply line that enters the eye through the optic nerve and feeds the entire inner layer of the retina. When this artery blocks, sight in that eye usually drops suddenly and without pain across the whole visual field. It is uncommon overall but becomes more frequent with age, occurring in roughly 12 of every 100,000 people per year among those in their early eighties. Not every central occlusion is permanent. A small number are brief and resolve on their own, and a small subset arise from arterial inflammation rather than a traveling clot or plaque fragment.
A branch occlusion blocks one of the smaller vessels that branch off downstream, starving only a wedge of the retina rather than the entire inner layer. People often describe a missing slice of their visual field, a dim step they notice only when covering the other eye, or no change at all. Because reading vision is processed in the central part of the retina, it often survives a branch occlusion even when a peripheral wedge is lost. In one large series of untreated eyes with a permanent branch blockage, roughly 74 out of every 100 could read 20/40 or better at the first visit, and that number improved over time. Good vision on the eye chart, however, reflects the condition of your retina, not your arteries.
Most retinal artery occlusions begin far from the eye. A fragment, most often cholesterol from atherosclerotic plaque in the carotid artery or the aorta, breaks loose and travels forward until a retinal vessel is too narrow to let it pass. Roughly 80 out of every 100 retinal emboli are of this cholesterol type, sometimes called Hollenhorst plaques. The source of that debris remains in place until someone finds and addresses it, which is why the evaluation after either type of occlusion reaches well beyond the eye itself.
How Branch and Central Occlusions Compare
These two conditions differ most when it comes to what happens to vision. When it comes to the risk they pose to the rest of the body, they are far more alike than their names suggest. Understanding both columns helps explain why the workup is equally thorough regardless of which type you have.
Central occlusions carry a more serious outlook for vision. Fewer than 20 out of every 100 people with a central occlusion regain useful sharpness in the affected eye. The window for any intervention is measured in hours, with animal studies showing that retinal tissue survives without detectable damage when circulation is restored within roughly 97 minutes, while roughly 240 minutes produces massive irreversible injury. Branch occlusions tend to carry a more encouraging outlook. Among eyes with a permanent branch blockage, roughly 89 out of every 100 reached reading vision of 20/40 or better over time. Visual field defects, meaning the missing wedge rather than sharpness, improved in roughly half of affected eyes, though many do not fully close.
This is where the two conditions look far more alike, and it is the part of the picture that should shape your next several weeks. In one study following 131 patients for up to 11 years, later stroke occurred in roughly 11 out of every 100 people with a central occlusion and roughly 8 out of every 100 with a branch occlusion. The difference was not statistically significant, and the authors concluded that both types carry a similar outlook for stroke, heart attack, and death. Carotid plaque was found on imaging in roughly 91 out of every 100 central occlusion patients and roughly 72 out of every 100 branch occlusion patients. Severe carotid narrowing was present at similar rates in both groups. Because the body-wide risk is comparable, both types warrant the same thorough vascular evaluation.
Expect two parallel tracks after either type of occlusion. The eye track uses dilated examination and retinal imaging to map the damage. The body track hunts for the source of the blockage. The recommended evaluation after a retinal embolus includes carotid duplex ultrasound to look at the neck arteries, an electrocardiogram to check for atrial fibrillation, echocardiography to look for a cardiac source, and CT or MRI angiography of the neck vessels, along with referral to primary care for a full vascular assessment. Blood pressure, cholesterol, and blood sugar are typically reviewed as well. If you are over 50, blood tests for arterial inflammation are usually added on the same visit.
Why a Branch Occlusion Is Still Treated as an Emergency
Several pieces of evidence explain why the smaller label does not translate into a slower response. The reasoning comes from how the body classifies these events, what brain imaging consistently finds, and the importance of ruling out one particular inflammatory cause that can threaten the second eye quickly.
A stroke is defined by where tissue dies from lost blood flow, not by how much the person noticed. The American Heart Association classifies retinal infarction, meaning tissue death in the retina caused by blocked circulation, as a form of acute ischemic stroke and calls for rapid triage to the nearest emergency department. Telling the front desk that you have had a retinal artery occlusion, a form of stroke, will move you through triage faster than describing a blurry patch. That framing is accurate and medically appropriate.
This is one of the most important reasons not to minimize a branch occlusion. In pooled groups of patients scanned by MRI within 7 days of an occlusion, fresh brain injury was present in roughly 30 out of every 100 people with a central occlusion and roughly 25 out of every 100 with a branch occlusion. Most of that brain injury caused no neurological symptoms at all. A scan can find what your eye chart cannot, and finding silent brain injury changes which treatments are offered and how urgently the vascular source is addressed.
One cause of retinal artery occlusion is inflammatory rather than embolic, and it must be identified quickly because it can reach the second eye within days. Giant cell arteritis is an inflammation of medium and large arteries that occurs primarily in people over 50. When it is the cause or is strongly suspected, urgent corticosteroid treatment is recommended to try to preserve vision in the affected eye and protect the other. If you are over 50, your care team will ask about new headaches, scalp tenderness, jaw aching when you chew, unexplained fever, or unintentional weight loss. Answer those questions carefully. Blood tests are typically ordered the same day, and treatment often begins while results are still pending.
Outlook and Risks After a Retinal Artery Occlusion
Knowing what to expect after a diagnosis helps you ask better questions and follow through on the monitoring that matters most. Outcomes vary, and averages describe groups rather than individuals, but the patterns are consistent enough to be worth knowing.
The picture for central vision is often encouraging, while field recovery is less predictable. Among branch occlusion eyes with abnormal visual fields, central field defects improved in roughly 47 out of every 100 and peripheral defects improved in roughly 52 out of every 100. That means a gap that often softens, but not one that reliably closes. Formal visual field testing gives a more complete picture than a standard eye chart, since the chart can look normal while a wedge of peripheral vision is missing.
The honest answer is more difficult. Fewer than 20 out of every 100 people with a central occlusion regain useful vision in the affected eye. Among eyes seen within 7 days with severely reduced vision, sight improved in roughly 22 out of every 100 cases and remained the same in roughly 66 out of every 100. There are currently no proven treatments to reverse the vision loss once a central occlusion has occurred, and the evidence does not support clot-dissolving therapy delivered into the vein or artery as a reliable option. Clinical trials for early intervention are ongoing. The care with the clearest proven benefit focuses on the vascular source, to reduce the chance that another event follows.
The first month after a retinal artery occlusion carries the highest risk of a subsequent stroke. A large analysis pooling data from 12 studies found that people with a retinal artery occlusion had a stroke rate roughly 3.6 times that of comparison groups, with roughly 4 out of every 100 experiencing a stroke within the first 30 days. That rate fell sharply after the first month, to roughly 1 out of every 200 between days 31 and 90. Most people in those studies did not have a stroke. The data support completing the vascular workup quickly and not deferring it for weeks.
A minority of eyes develop new, fragile blood vessels weeks to months after an occlusion. This happens more often when a large area of the retina has been starved of blood flow. These new vessels can raise eye pressure and threaten sight again. Panretinal photocoagulation, a laser treatment applied to the peripheral retina, is recommended when new vessels appear on the iris or retina. A red, painful eye with halos around lights is a same-day concern. Keeping your scheduled follow-up appointments is the most reliable way to catch these changes early, when laser treatment remains a straightforward option.
Your Care Team and What to Expect Next
After a retinal artery occlusion, your care involves more than one specialty working in parallel. Knowing who is responsible for each part of the evaluation helps you stay on track and makes sure nothing falls through the gap between appointments.
Contact your Retina Specialist the same day if you notice a new or growing blind patch, a sudden drop in sharpness, a curtain or shadow across your sight, new floaters or flashing lights, or a red painful eye with halos around lights. These symptoms can signal a change that needs to be seen and documented right away. For any neurological symptoms, including weakness on one side, facial droop, difficulty speaking, or sudden severe headache, call 911 immediately.
Your care team typically involves three parts: a Retina Specialist managing the eye, a stroke or vascular service tracing the source, and your primary care provider coordinating the broader plan. People with retinal cholesterol emboli have a meaningfully higher rate of future stroke than the general population, which is why the vascular and cardiac testing runs alongside the eye follow-up rather than waiting until later. Before you leave any appointment, ask for your next visit date and confirm who is booking the neck and cardiac tests. If a planned test has not been scheduled within a week, follow up directly to make sure it happens.
Writing down answers during your appointment helps you track next steps and share information with your other providers. Consider asking these questions at your visit.
- Which type of occlusion do I have: central, branch, or another subtype?
- Which part of my visual field is affected, and can I have formal field testing?
- Has giant cell arteritis been ruled out, and which blood tests were used?
- Who is arranging my carotid imaging, echocardiogram, and heart rhythm monitoring, and by when?
- Are any of my current medications for blood pressure, cholesterol, or heart rhythm being adjusted because of this?
- Which symptoms should bring me back the same day rather than waiting for my next appointment?
Frequently Asked Questions
These answers address questions that often come up after a diagnosis, particularly around timing, testing, and what to expect going forward.
If the change happened in the last day or two, treat it as urgent and say so when you call. The priority is not just your eye but finding the source of the blockage before another fragment travels somewhere more dangerous. Even when a branch occlusion is found by chance with no symptoms, a timely referral is still advised. Asking for a same-day evaluation is appropriate, and most retinal practices expect and accommodate that call for this type of event.
Yes, because the eye chart measures a small patch of central retina rather than your arteries or your brain. Silent brain injury from a concurrent stroke is present in roughly one in four branch occlusion cases and causes no neurological symptoms in many of those people. Finding that injury changes treatment decisions, including which blood thinners or vascular interventions are considered and how urgently a narrowed carotid artery is addressed. Good vision is genuinely good news for your eye. It is not a measure of what is happening in your circulation.
It sometimes shrinks over time, often partially remains, and cannot be reliably predicted for any individual. Field recovery is tracked best with formal perimetry testing, which maps the full visual field rather than just central sharpness. Ask for that test at your first visit and repeat it over the following months. Comparing the maps side by side gives your Retina Specialist and you a clear picture of whether the defect is stable, improving, or changing in a way that warrants attention. The results also matter for driving evaluation and workplace accommodations if those are relevant for you.
There is no reliably proven treatment to reverse the vision loss once a retinal artery occlusion has occurred. Evidence does not currently support clot-dissolving therapy delivered into a vein or artery as a standard approach for most patients, and the acute treatment window is very short regardless. Some clinical trials are evaluating early interventions, and your care team may discuss options depending on how recently the event occurred and your overall health. The clearest benefit from treatment comes from addressing the underlying vascular source to reduce the chance of a future event in the eye or the brain.
In most cases, the other eye is not in immediate danger, because these events typically affect one eye at a time when caused by a traveling embolus. The important exception is giant cell arteritis, which is an inflammatory condition that can affect both eyes in rapid succession if not treated. Until arteritis has been ruled out, both eyes are considered at risk. After that is excluded, monitoring the second eye at home by covering each eye briefly once a week and checking for new gaps or blurring in a line of text is a practical habit your Retina Specialist may recommend.
Driving eligibility depends on your specific visual field results and the legal standards in your state, not just your eye chart reading. A missing wedge of peripheral vision can be more relevant to driving safety than the letters you can read at a distance. Ask your Retina Specialist for formal visual field testing and a direct conversation about how your results compare with your state's licensing requirements. If driving is part of your work, ask for the test results in writing so you have documentation for your employer or licensing authority.
Retina Care for the Eastern Shore of Maryland and Delaware
Atlantic Retina Center is a single-specialty vitreoretinal practice, meaning our entire focus is on the retina, vitreous, and macula. Our fellowship-trained, board-certified Retina Specialists have the training and experience to evaluate both branch and central retinal artery occlusions thoroughly, from diagnosing the type and extent of the blockage to coordinating the vascular workup that follows. If you or someone you care about has experienced a sudden change in vision, we encourage you to contact us right away so we can help you understand what happened and what comes next.